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ABSTRACT

Behavioral experiments examined the role of morphiceptin in male rat copulatory
behavior. Male copulatory behavior was recorded subsequent to bilateral injections of
either 10, 500, or 1000 ng of morphiceptin into the medial preoptic area (MPOA) in
sexually vigorous male rats.

In the first experiment, all three doses of morphiceptin

injected bilaterally into the MPOA produced a dramatic delay in the initiation of copulation.
Both mount and intromission latencies significantly increased following injections of all
three doses of morphiceptin when compared to saline injected controls.

No other

tJ

parameter was effected. In experiment 2, the inhibitory effects of morphiceptin on male
copulatory behavior were abolished by pretreatment with naloxone 20 minutes prior to
intracerebral morphiceptin injections.

This study represents an attempt at a

pharmacological characterization of the inhibitory effects of opioids on male rat sexual
behavior. The results of experiment 1 indicate that mu receptors located within the MPOA
mediate the initiation of male rat copulatory behavior.

•

GENERAL INTRODUCTION

A richly interconnected, sexually dimorphic circuit which includes the medial
amygdala (MA), the bed nucleus of the stria terminalis (BnST) , and the medial preoptic
area (MPOA) has been reported to be an important pathway for the expression of male
sexual behavior in rodents (see (9) for review). In particular, lesions of the MPOA have
been reported to severely impair copulation and even to eliminate sexual behavior
completely in a wide range of species (1,4,12,29,35); while electrical stimulation of the
MPOA enhances the

expr~ssion

of male copulatory behavior (17,19).

The dramatic

effects on male copulatory behavior following lesions or electrical stimulation of the MPOA
as compared to other brain structures, imply that the MPOA plays a central role in
regulating male sexual behavior in the laboratory rat (see (31) for review).
Although the importance of this interconnected circuit for male rat sexual behavior
has been clearly demonstrated, one of the fundamental questions that remains to be
answered is the identity of the neurotransmitter(s) within the circuit that regulates male
copulatory behavior.

Recently, experimental interest has focused on the idea that

neuropeptides within the sexually dimorphic circuit play an important role in the regulation
of male sexual behavior (7,8,33,34), (see (9) for review). One class of neuropeptide which
is found in this circLiit is the opioid peptide. Indeed, there is a wealth of information which

s

reveals that the administration of opioid agonists inhibit sexual behavior in mammals, non
t1

human primates and humans (13,18,32), see (27) for review).
One opioid of particular interest is beta-endorphin.

Meyerson and Terenius
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reported that three different doses (1, 3 and 30 micrograms) of beta-endorphin injected
into the lateral ventricles (ICV) produced a dose-dependent inhibition of copulatory
behavior in male rats. This effect was blocked by peripheral injections of naltrexone 30
minutes before ICV injections of beta-endorphin (21). In a subsequent study, Meyerson
again reported an inhibition of copulatory behavior following injections of beta-endorphin
at lower doses (0.5 and 1.0 micrograms) into the cerebral ventricles. Interestingly, he also
reported that although morphine, another opioid, had similar effects on copulatory
behavior as beta-endorphin, morphine was not specific in that it suppressed a number of
behaviors that beta-endorphin did not (20).
It is surprising that until 1987 no published reports existed in the literature on the
effects of opioid agonists on male sexual behavior following injections directly into brain
loci implicated in male sexual behavior. Hughes et al. (14) were the first to examine the
effects of injections of beta-endorphin into the sexually dimorphic circuit.

Bilateral

injections of beta-endorphin into the MPOA in male rats produced a dose-dependent
inhibition of male copulatory behavior:

mount, intromission and ejaculation latencies

increased while the mount rates (mounts/min) decreased.

In order to assess the

anatomical specificity of action of beta-endorphin on male sexual behavior, in that same
study beta-endorphin was also injected into the Bnst, another area implicated in male
sexual behavior and located near the MPOA. Identical doses of beta-endorphin which
produced a profound inhibition of male copulatory behavior in the MPOA, had no effect
following bilateral injections into the BnST (14).
Recently, there has been much speculation in the literature about the possible
involvement of different opioid receptors in the regulation of male copulatol)' behavior.
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The impetus for this has been derived from studies which have reported that selective
activation of different opioid receptors have differential effects on sexual receptivity in
ovariectomized-estrogen primed female rats. It appears that activation of high affinity mu
receptors inhibit sexual receptivity, whereas mUz or delta receptor activation produce an
inhibition (26,28).

Based on such findings on female sexual behavior, studies have

expanded to examine the behavioral effects of differential opioid receptor activation on
copulatory behavior in male rats.

Indeed, although opioid agonists have long been

recognized as playing a predominantly inhibitory role in male sexual behavior, this dogma
has recently been challenged. Band and Hull reported that unilateral injections of low
doses of morphine (a relatively selective mu agonist) and dynorphin (a kappa agonist) into
the MPOA of male rats produced a facilitation in copulatory behavior at 10-100 pmol.
Males injected with a higher dose of morphine (6 nmol), however, showed an inhibition
in copulatory behavior by failing to intromit after the second ejaculation. Band and Hull
postulated that the different effects of morphine on male sexual behavior could be
attributed to mUltiple receptor subtype activation (2). Indeed, morphine is only 50 times
't\.

more potent at mu receptors that at delta receptors (23).

Given the relative lack of

specificity of morphine for individual opioid receptor subtypes, it is possible that the
differential effects of morphine could be attributed to activation of different opioid receptor
subtypes.
Therefore, a crucial step in assessing the role of opioids on male copulatory
behavior is to elucidate the receptor subtype involved. Presently, however, it is not clear
which receptor type mediates the inhibition of male copulatory behavior following central
administration of opioid agonist. For example, beta-endorphin displays equal affinity to •
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mu and delta receptors (16). Consequently, it is impossible to assess based on the
results of the Hughes et al study which opioid receptor type located within the MPOA
mediates the inhibition of male copulatory behavior.

In contrast, morphiceptin is

considered a selective opioid receptor agonist with a 1000 times greater affinity for mu
than delta or kappa receptors (5,6). Therefore, in the present study, I assessed the role
of mu receptors in male copulatory behavior following bilateral injections of morphiceptin
into the MPOA.

•
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GENERAL METHODS

Animals and Surgery:
Thirty adult male Long-Evan rats purchased from Charles River, Wilmington, MA,
were used. The animals weighed between 375 and 450 grams. The rats were housed
individually and maintained in a controlled environment on a light/dark cycle (lights on at
6:00 and off at 21 :00). Animals were handled on a regular basis to minimize stress during
intercerebral injections. Food and water were available ad lib throughout the experiment.
Stimulus females of the same strain were ovariectomized under ether. Fifty-three hours
and 4 hours before each behavioral test, females were injected subcutaneously with 10
micrograms of estradiol benzoate and 1 microgram progesterone respectively, to ensure
maximal sexual receptivity. Each male was given preoperative screening tests in which
it was placed with a fully receptive female until one ejaculation was achieved. Only males
that had ejaculated at least twice during the screening tests were subsequently used.
Following the second or third successful preoperative test session, each male was
anesthetized with Somnotol (50mg/kg) and received a pair of stereotaxically implanted 22
gauge stainless steel guide cannulae, aimed 2mm above the medial preoptic area (MPOA)
(from bregma, AP

= + 2/2;

ML

= -D.5;

and DV

= -6.3) using the atlas

of Paxinos and

Watson as a guide (24). The cannulae were secured with cranioplastic cement.
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Behavioral Testing:
One week following the surgery the males were given a postoperative test in
rectangular test arenas (20 x 15 x 14 in.) with standard bedding to obtain baseline
measures. Ovariectomized, steroid-primed female rats were placed in the arena with the
male rat. If a male failed to mount or intromit within the first five minutes of the baseline
test, he was given another baseline test one week later. Those that failed the second
baseline test were excluded from this study.
All males that successfully completed a baseline test received injections of saline
or morphiceptin seven days later.

During experimental and baseline tests several

measures were taken: mount latency (ML), the interval from the introduction of the female
to the first mount by the male; intromission latency (IL), the interval from the introduction
to the first intromission; the ejaculation latency (EL), the interval from the first intromission
to the first ejaculation; the post-ejaculatory interval (PEl), the interval from the first
ejaculation to the next mount; the mount frequency (MF), the number of mounts without
intromission between the introduction and the ejaculation; the intromission frequency (IF),
the number of intromissions between the introduction and the ejaculation; and the number
1

of crawls exhibited. The last measure was taken to provide another measure of sexual
motivation beside mount latency. The test period lasted either 30 minutes or until the first
mount following ejaculation (PEl). The intercopulatory interval (lei), mean interval between
intromissions, was also obtained by dividing the overall ejaculation latency by the
intromission frequency. Animals that failed to mount, intromit or ejaculate during the
morphiceptin testing were assigned latencies of 900 second, the duration of the
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observation period (14).

Intracerebral Injections:

Rats were taken from their cages and individually placed on a table in a low light,
low noise situation. The 26 gauge inner cannula (extending 2 mm past the guide) was
attached to a 2 microliter syringe by a plastic tube. Distilled water was drawn through the
tube until 1 microgram of distilled water could be drawn and expelled. An air bubble was
then drawn through the tube to mark the separation between the distilled solution and the
morphiceptin solution.

Half a microliter of either 10, 500 or 1000 nanogram of

morphiceptin in a 9% saline solution or saline was injected manually over 60 seconds into
each side of the brain. The inner cannula was left in place for 60 seconds following the
injection to insure that the solution diffused downward rather than returning up the
cannula. If a discrepancy arose as to the movement of the air bubble, another dose was
administered. Five minutes after the injection, the testing session began.

Histological Analysis:

Following data acquisition, all animals were anesthetized with an overdose of
SomnotoJ. Brains were removed and 46 micron sections taken using a cryostat. Sections
were stained using cresyl violet and the location of each cannula placement was verified.

Data Analysis:
Unless otherwise stated, all data were analyzed using an unweighted means
analysis of variance (ANOVA) in a repeated measures split-plot design:

Post-hoc
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comparisons of treatment means were assessed using a modified Tukey's ratio, required
when an unweighted-means of analysis is employed (15).

EXPERIMENT 1: PREOPTIC INJECTIONS OF MORPHICEPTIN
INHIBIT MALE COPULATORY BEHAVIOR

Method:
Thirty-one adult male Long Evans rats (375-450 grams) were divide.d into four
groups.

Three groups received bilateral injections of either 10, 500, or 1000 ng of

morphiceptin/cannula in a volume of 0.5 microliter per cannula (Sigma Chemical
Company, lot No. 84F-58352) dissolved in 0.9% saline into the MPOA. The fourth group
was injected with saline.

Results:

.Of the thirty-one animals that began the study, two had both cannulae located
outside the MPOA, four had only ona cannulae located within the MPOA, and three never
satisfied criterion at the postoperative baseline test. That left twenty-two animals for the
data analysis (controls, n = 7; 10 ng, n = 3; 500 ng, n = 6; 1000 ng, n = 7, (see figure
1 for a representative placement site). As illustrated in Table 1 bilateral injections of three
different doses of morphiceptin significantly delayed the initiation of copulatory behavior
compared to an injection of saline alone. This was revealed by a significant main effect
on mount and intromission latencies F (3,18)

= 6.68, P

< 0.01); F (3,18)

= 4.57, P <

0.01, respectively). This is also illustrated in figures 2 and 3. Post hoc analysis, however,
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revealed that morphiceptin did not increase mount and intromission latencies in a dosedependent manner. No other parameter was affected. For example, as can be seen in
figure 4, morphiceptin failed to significantly alter ejaculation latencies (F = 1.26, P > O.OS).
As illustrated in table 1, following injections of morphiceptin, 14 % (1000 ng) and 28 %
(500 ng) of the males failed to mount or intromit.
Bilateral injections of morphiceptin into the MPOA failed to alter significantly
ejaculation latency (F

= 1.26, P > O.OS), the PEl

(F

= 0.47, P > O.OS) or the mount and

intromission frequencies (F = 1.90, P > 0.05; F = 0.23, P > 0.05, respectively) when
compared to the saline injections (see Figure 4, and Table 1).

EXPERIMENT 2: PRETREATMENT WITH NALOXONE BLOCKED THE
EFFECTS OF MORPHICEPTIN INJECTIONS ON COPULATORY BEHAVIOR

The preceding experiment demonstrated that bilateral injections of morphiceptin
into the MPOA produced a dramatic inhibition of male copulatory behavior when
compared to saline injected controls.

In this experiment, we examined whether the

inhibitory effects of morphiceptin on male copulatory could be blocked with pretreatment
of a non-selective opioid antagonist (naloxone).

Method:
Following completion of the last behavioral test in experiment 1, all remaining
animals were randomly divided into two groups. Group 1 received an IP injection of
1mg/kg naloxone (lot No. 128F-0264) 20 minutes prior to bilateral injections of 1000 ng
of morphiceptin directly into the MPOA. Group 2 was pretreated with saline. Since the

I
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1000 ng dose of morphiceptin produced the greatest delay in the initiation of copulation,
we decided to examine the effects on male copulatory behavior following pretreatment
with naloxone using bilateral injections of 1000 ng of morphiceptin into the MPOA.

Results:
As in Experiment 1, bilateral injections of morphiceptin increased mount and
intromission latencies in saline pretreated animals. Pretreatment with naloxone completely
abolished the inhibitory effects of morphiceptin (see figure 5).
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DISCUSSION

Bilateral microinjections of three different doses of morphiceptin in the MPOA
produced a dramatic delay in the initiation of copulation in sexually vigorous male rats
when compared to saline injected controls. This inhibition was completely abolished by
pretreatment 20 minutes prior to morphiceptin microinjections with naloxone (1 mg/kg)
injected IP. These results provide further support that the MPOA is an important site of
action for the inhibitory effects of peripherally administered opioids. Moreover, these
results strongly suggest that the delay in the initiation of copulation that is commonly
observed following peripheral or central injections of opioids is mediated by mu receptors
located within the MPOA.
The results of this study partly conflict with other studies which have assessed male
copulatory behavior following administration of non-selective opioid agonists.

For

example, no effect was observed on ejaculatory threshold following injections of
morphiceptin (see table 1).

This discrepancy can be partly explained by the

pharmacological profile of the agonists employed in the various studies. For example, in
the Hughes et al. study, significant increases in mount, intromission and ejaculation
latencies were observed following bilateral injections of beta-endorphin into the MPOA
(14). Beta-endorphin, a prototypical opioid, binds equally well to both mu and delta
receptors. Thus, the inhibition on male sexual behavior observed in the Hughes et al.
study may have been partially mediated via delta receptors. Indeed, pretreatment with a
putative delta receptor antagonist (leI 174864) prevented the inhibition of male sexual
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behavior following bilateral injections of beta-endorphin into the MPOA. Therefore, the
results from my study taken together with Hughes' study, suggest that mu receptors
mediate the initiation, while delta receptors may be involved in the ejaculatory threshold
or the resolution of the copulatory sequence once copulation is initiated.
In the literature it has been frequently reported that beta-endorphin injections
produce a "MPOA lesion-like behavior" in male rats; that is, the male vigorously pursues
the female but his performance halts at the point when he would normally mount her
(14,20,21). This is not surprising based on the findings of several recent studies which
have reported that neurochemical lesions of the MPOA in male rats lead to a dramatic
disruption of male copulatory behavior but have no effect on operant responding for a
sexual receptive female (10). In this type of paradigm males will bar press reliably for a
female, but once the female is introduced, the males fail to mount or intromit. MPOA
lesion-like behavior was repeatedly seen in this study as well. Following injections of all
three doses of morphiceptin into the MPOA the males would almost immediately pursue
and investigate the female anogenitally. Indeed contact latencies remained relatively low
(means in seconds: 1000 ng

= 72.0;

500 ng

= 410.81;

10 ng

=

18.66) following

morphiceptin injections despite the dramatic increase in mount and intromission latencies.
Therefore, it seems that morphiceptin like beta-endorphin injections into the MPOA does
not interfere with the initial interest or access to the female, but interferes with an
organization component of the motor pattern of sexual behavior.

Beach (3) proposed

that, contrary to viewing sexual behavior as a unitary construct, two separate mechanisms
were involved in male reproductive behavior: a sexual arousal mechanism and a
copulatory mechanism. He suggested that the arousal mechanism mediates the male's •
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initiation of the copulatory sequence, as well as the resumption of copulation following
ejaculation. The copulatory mechanism was assumed to maintain copulatory behavior by
summating the excitation of each successive intromission until ejaculation occurred.
Since its original formulation the "two factor" theory of Beach has received considerable
attention. As a result, its conceptual framework has been continually revised. Based on
a factor analysis of normative data on sexual behavior in male rats, Sachs (30)
subsequently subdivided the copulatory mechanism into further dimensions, one of which
he referred to as a "copulatory rat factor". This factor contained three components: inter
intromission interval (which has been referred to as the ICI), ejaculation latency, and the
post-ejaculatory interval (PEl). The reason for the inclusion of the PEl in the theoretical
copulatory mechanism framework was to account for the relative independence of the PEl
from mount and intromission latencies (two behavioral components associated with
arousal). Collectively, the results of this study strongly suggest that in addition to the
mediation of the initiation of copulation, mu receptors located within the MPOA may be
partly involved in arousal but have no role in the copulatory mechanism of male rat sexual
behavior.
For example, as previously mentioned following the termination of a pursuit, the
male would show considerable interest in the female but would not mount her. This was
often followed by flank grooming and scratching. On other occasions, however, after an
abortive mount, the male would lose interest in the female, sometimes for as long as 2 or
3 minutes.
In this study motor activity was not measured. The rationale for this is straight
forward, there are many studies which have now been pUblished using a variety of •
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approaches to measure motor activity following the administration of opioid agonists,
which have concluded that at low doses, opioids inhibit male copulatory behavior without
affecting locomotor activity (11,14,21,22,25).

The findings of low contact latencies

following morphiceptin injections further substantiate this conclusion that the disruption
of male sexual behavior was not due to a general behavioral inhibition.
In conclusion, the results of this study further support the importance of the opioid
innervation of the MPOA in the regulation of male copulatory behavior. Furthermore, as
a result of the pharmacological characterization of the specific receptor involved in the
inhibition of male copulatory behavior, these results suggest that the initiation of copulation
in the male rat is mediated via mu receptors and the ejaculatory threshold via another
opioid receptor.

Clearly, further research remains to be done using selective mu

antagonists, as well as highly selective agonists before the role of different opioid
receptors in the regulation of male copulatory behavior is clearly elucidated. Nonetheless,
it is hoped that these results will facilitate the understanding of the role of different opioid
receptor regulation of male rat copulatory behavior and as a result provide further insight
into the role of endogenous opioids in the neuroregulation of male sexual behavior.
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TABLE 1
E:~per-irnef1t

1.: Effects of InjectiDns 01 ~,aJ i/lE' or- Morphiceptin
into the 1"1POA on 1"1ale Sf.?>:ual Ophav;or

1'1 (J r phi c: F' P tin

Ileasures

Ill""
Bas!!line
Experhental
IlF
Baseline
Experilllental
Il
Baseline
Experilliental
IF
Baseline
Experimental
El
Baseline
Experimen ta I
leI
Baseline
Experiftlental
PEl
Baseline
Experhental
XE
Baseline
Experimental

Saline

10 ng

500 ng

1000 ng

7.38 ! 1.36
9.96 :!:. 2.07

11. 80 ~ 5.7
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FIGURE 1. Summarizes a representative bilateral cannula placement in males which
received injections of either 10, 500 or 1000 ng of morphiceptin into the MPOA in
experiments 1 and 2. Abbreviations: ac, anterior commissure; cc, corpus callosum; CPu,
caudate putamen; GP, globus pallidus; f, fornix; ic, internal capsule; 3V, third ventricle;
MPOA, medial preoptic area; oc, optic chiasm.
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FIGURE 2. Comparison of the effect of morphiceptin injections to saline injections into the
MPOA on mean mount latencies.

The 10, 500 and 1000 ng doses delayed the

occurrence of mounts significantly.

Error bars in this and following figures display

standard error on the difference between means.
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FIGURE 3. Comparison of the effect of morphiceptin injections to saline injections into the
MPOA on mean intromission latencies. The 10, 500 and 1000 ng doses delayed the
occurrence of intromissions significantly.

•

700
_

600
>

u
z

W
i

«
---.J

z
o
(j)
(j)

5.00

saline
~ 10 ng
~ 500 ng
CJ 1000 ng

400
300

:2

o
cr:

i
Z

200
100

BASELINE

INJECTION

•

FIGURE 4. Comparison of the effect of morphiceptin injections to saline injections into the
MPOA on mean duration to ejaculation from the first intromission.
doses significantly effected the ejaculation latency.

None of the three
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FIGURE 5. Effects of naloxone

+ morphiceptin (1000 ng) injections compared to saline

+ morphiceptin (1000 ng) injections on mount, intromission and ejaculation latencies.
Naloxone blocked the inhibitory effects of morphiceptin injections on mount and
intromission latencies.
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